261 related articles for article (PubMed ID: 22723937)
1. MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.
Zhao Y; Li Y; Lou G; Zhao L; Xu Z; Zhang Y; He F
PLoS One; 2012; 7(6):e39102. PubMed ID: 22723937
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
Han L; Liu B; Jiang L; Liu J; Han S
Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
4. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
5. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.
Luo Q; Wei C; Li X; Li J; Chen L; Huang Y; Song H; Li D; Fang L
Oncol Rep; 2014 Mar; 31(3):1096-102. PubMed ID: 24402230
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.
Guo QJ; Mills JN; Bandurraga SG; Nogueira LM; Mason NJ; Camp ER; Larue AC; Turner DP; Findlay VJ
Breast Cancer Res; 2013; 15(4):R70. PubMed ID: 23971998
[TBL] [Abstract][Full Text] [Related]
8. A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis.
Chen Y; Zhou Y; Han F; Zhao Y; Tu M; Wang Y; Huang C; Fan S; Chen P; Yao X; Guan L; Yu AM; Gonzalez FJ; Huang M; Bi H
Theranostics; 2020; 10(16):7193-7210. PubMed ID: 32641987
[No Abstract] [Full Text] [Related]
9. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.
Shukla K; Sharma AK; Ward A; Will R; Hielscher T; Balwierz A; Breunig C; Münstermann E; König R; Keklikoglou I; Wiemann S
Mol Oncol; 2015 Jun; 9(6):1106-19. PubMed ID: 25732226
[TBL] [Abstract][Full Text] [Related]
11. miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRα.
Tribollet V; Barenton B; Kroiss A; Vincent S; Zhang L; Forcet C; Cerutti C; Périan S; Allioli N; Samarut J; Vanacker JM
PLoS One; 2016; 11(5):e0156445. PubMed ID: 27227989
[TBL] [Abstract][Full Text] [Related]
12. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.
Duhachek-Muggy S; Zolkiewska A
BMC Cancer; 2015 Mar; 15():93. PubMed ID: 25886595
[TBL] [Abstract][Full Text] [Related]
13. Tumour-suppressive microRNA-424-5p directly targets CCNE1 as potential prognostic markers in epithelial ovarian cancer.
Liu J; Gu Z; Tang Y; Hao J; Zhang C; Yang X
Cell Cycle; 2018; 17(3):309-318. PubMed ID: 29228869
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.
Wang X; Li Y; Qi W; Zhang N; Sun M; Huo Q; Cai C; Lv S; Yang Q
Oncotarget; 2015 Oct; 6(32):32737-47. PubMed ID: 26417931
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-16 modulates HuR regulation of cyclin E1 in breast cancer cells.
Guo X; Connick MC; Vanderhoof J; Ishak MA; Hartley RS
Int J Mol Sci; 2015 Mar; 16(4):7112-32. PubMed ID: 25830480
[TBL] [Abstract][Full Text] [Related]
16. Tumor-suppressive function of miR-139-5p in esophageal squamous cell carcinoma.
Liu R; Yang M; Meng Y; Liao J; Sheng J; Pu Y; Yin L; Kim SJ
PLoS One; 2013; 8(10):e77068. PubMed ID: 24204738
[TBL] [Abstract][Full Text] [Related]
17. WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration.
Dwyer MA; Joseph JD; Wade HE; Eaton ML; Kunder RS; Kazmin D; Chang CY; McDonnell DP
Cancer Res; 2010 Nov; 70(22):9298-308. PubMed ID: 20870744
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.
Li S; Xu JJ; Zhang QY
Cancer Sci; 2019 Oct; 110(10):3098-3109. PubMed ID: 31389121
[TBL] [Abstract][Full Text] [Related]
19. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
20. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
Tian X; Zhang Z
IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]